Centogene NV (STU:39K) Price-to-Operating-Cash-Flow : (As of Dec. 11, 2024)

View and export this data going back to 2019. Start your Free Trial

What is Centogene NV Price-to-Operating-Cash-Flow?

As of today (2024-12-11), Centogene NV's share price is €0.18. Centogene NV's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was €0.00. Hence, Centogene NV's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Centogene NV's Price-to-Operating-Cash-Flow or its related term are showing as below:

During the past 8 years, Centogene NV's highest Price-to-Operating-Cash-Flow Ratio was 27.84. The lowest was 6.82. And the median was 13.68.

STU:39K's Price-to-Operating-Cash-Flow is not ranked ^*
in the Medical Diagnostics & Research industry.
Industry Median: 18.065
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Centogene NV's Cash Flow from Operations per share for the three months ended in Dec. 2023 was €0.00. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was €0.00.

During the past 8 years, Centogene NV's highest 3-Year average Operating Cash Flow per Share Growth Rate was -25.80% per year. The lowest was -61.10% per year. And the median was -43.45% per year.

Centogene NV Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Centogene NV's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Centogene NV Price-to-Operating-Cash-Flow Chart

Centogene NV Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

21.91

Centogene NV Quarterly Data
	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Dec22	Jun23	Dec23
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Centogene NV's Price-to-Operating-Cash-Flow

For the Diagnostics & Research subindustry, Centogene NV's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Centogene NV's Price-to-Operating-Cash-Flow Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Centogene NV's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Centogene NV's Price-to-Operating-Cash-Flow falls into.

Centogene NV Price-to-Operating-Cash-Flow Calculation

Centogene NV's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	0.18	/	0
	=

Centogene NV's Share Price of today is €0.18.
Centogene NV's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Centogene NV Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Centogene NV's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Centogene NV Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Centogene NV (STU:39K) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

CNTGF:USA

Address

Am Strande 7, Rostock, MV, DEU, 18055

Website

https://www.centogene.com

Centogene NV is a United States-based company engaged in data-driven answers to patients, physicians, and pharmaceutical companies for rare and neurodegenerative diseases. The company operates in two segments: pharmaceutical and diagnostics. Its pharmaceutical segment provides a variety of services to its pharmaceutical partners, including early patient recruitment and identification, epidemiological insights, biomarker discovery, and patient monitoring. Its diagnostics segment provides targeted genetic sequencing and diagnostics services to patients. Its geographic regions are Europe, the Middle East, North America, and Latin America.

Centogene NV Headlines

No Headlines